top of page
Report.png
In Vitro Diagnostics Quality Control Market

In Vitro Diagnostics Quality Control Market Size, Share, Competitive Landscape and Trend Analysis Report by Product & Services, Technology and End-user: Global Opportunity and Industry Forecast (2025-2032)

Report ID:

1175

Industry:

Healthcare

Published on:

March 2026

In Vitro Diagnostics Quality Control Market had a value of USD 1.35 billion in 2025 and expected it to hit USD 1.84 billion by 2032, with a CAGR of 4.5% through the forecast period.

In Vitro Diagnostics Quality Control Trends and Analytical Insights -

  • North America In Vitro Diagnostics Quality Control Market was the largest revenue generating region market in year 2025, with market share accounted for 38.11%.

  • In 2025, By Quality Control Products segment dominated the In Vitro Diagnostics Quality Control Market, accounted for 46.12 % market shares.

  • Leading Key players for In Vitro Diagnostics Quality Control Market in 2025 was Siemens Healthineers AG, Abbott and Bio-Rad Laboratories.

Market Size & Forecast

  • Market Size 2025: USD 1.35 Billion

  • Projected Market Size 2032: USD 1.84 Billion

  • CAGR (2025-2032): 4.5%

  • Asia Pacific: Dominating market in 2025

In Vitro Diagnostics Quality Control Market Overview

The In Vitro Diagnostics Quality Control Market was representing an industry that was producing, providing and/or developing products and/or services to assist with the accuracy, reliability and consistency of all tests being performed on materials taken from outside of the body in laboratory settings. Tests being performed were including blood work, urine tests, molecular testing, and immunological testing being performed in hospitals or clinical laboratories. The In Vitro Diagnostics Quality Control Market was being very important in ensuring test accuracy, ensuring laboratories were complying with regulations, and facilitating laboratory productivity. Most laboratories were also adopting a standardized type of control material as well as implementing automated monitoring systems to manage quality assurance. In addition, the laboratory testing volumes between 2021 and 2025 were being estimated to expand at approximately 7 to 9% per year for both hospital laboratories and independent diagnostic facilities. The healthcare system was implementing digital quality assurance systems to monitor the accuracy of thousands of daily diagnostic tests.

Another rapidly rising, and therefore valuable market, was the In Vitro Diagnostics (IVD) Quality Control Market; as a result of the increased emphasis on patient safety initiatives, most healthcare systems were requiring assurance through the use of accredited laboratories. By 2024, almost 70% of large diagnostic labs were being expected to have implemented multi-level quality control protocols for regularly performed testing. Digital analyzers were being produced by diagnostics equipment manufacturers with built-in quality monitoring features to assure standardization in all testing performed. Therefore, at that time, approximately 14 billion diagnostic laboratory tests were being performed internationally by clinical laboratories every year and most laboratories were continuing to use both internal and external control materials to ensure the reliability (accuracy) of their testing. Also, as a result of the rapidly growing adoption of laboratory quality control solutions, hospital, reference and point of care testing laboratories were increasingly adopting these solutions. The continued trend toward greater automation of laboratories and increased testing volumes was also contributing to the further support and strengthening of quality assurance solutions throughout all segments of the healthcare system.

In Vitro Diagnostics Quality Control Market Dynamic’s

With rapid growth in Diagnostic Lab Testing, the In Vitro Diagnostic Quality Control Market was performing well for years as Healthcare Lab Facilities were placing more emphasis on test accuracy & laboratory compliance. Many diagnostic labs were completing thousands of tests daily; quality control systems were enabling these laboratories to produce consistent trustworthy test results. Hospital laboratories, supporting large HealthCare Facilities, were processing 2500 to 3200 diagnostic samples per average day from 2022 through 2025. Commercial Electronic Laboratory Quality Control Musculoskeletal Diagnostic Instruments (with high-quality signal processing capabilities) were experiencing similar benefits as Lab Testing Automation (requiring ongoing verification of equipment) was continuing to increase across all Clinical Laboratories by utilizing instruments & devices manufactured with an increase in Electronic Laboratory Quality Control Systems, and approximately 2500 of accredited laboratories were establishing a multi-stage Laboratory Quality Control System (i.e. multiple stages of laboratory quality control). In addition, many diagnostic labs were integrating Digital Dashboards capable of providing real-time tracking of laboratory quality measurements, giving laboratories a way to identify test failure points immediately during the test process.

Operational challenges in the In Vitro Diagnostics Quality Control Market were including maintaining cost effectiveness through laboratory training as well as effective overall management of limited budgets, with many laboratories managing limited budget constraints while maintaining stringent testing standards. Most laboratories were still utilizing manual quality control processes, which were increasing the overhead operational workload as a result of their manual implementation; however, changing technologies were presenting In Vitro Diagnostics Quality Control Market additional opportunities through innovative use of technology including record keeping and evaluation of large diagnostic quality control datasets in cloud-based systems. In 2023, over 40% of laboratories were going to have fully adopted automated data management to improve centralized quality assurance of laboratory equipment. New tools combining artificial intelligence with traditional quality assurance methods were becoming available to support laboratories in identifying and addressing quality variances in testing and improving laboratory efficiency.

The recent happenings in the In Vitro Diagnostics Quality Control Market were being characterized by ongoing innovation among diagnostic solution providers. Many new multi-analyte control materials were being introduced to be used all across the many different forms of diagnostic technology. Over the period of 2023-2025 more than 30 new products were being introduced for immunochemistry, Hematology, and molecular diagnostics platforms. The In Vitro Diagnostics Quality Control Market was experiencing an increase in the level of integration that was existing between laboratory information systems and quality monitoring software. Collaborations were being developed between several manufacturers and hospital networks for the purpose of developing diagnostic standardization in numerous laboratories. Digital management solutions were being utilized to analyze thousands of daily test results and identify performance trends that were occurring with diagnostic equipment.

In Vitro Diagnostics Quality Control Market Segment Analysis

The In Vitro Diagnostics Quality Control Market segmented into By Product & Services, Technology and End-user.

By Product,

Based on the product & services, the market was segmented into Quality Control Products, Data Management Solutions, and Quality Assurance Services. In 2025, the Quality Control Products segment dominated the In Vitro Diagnostics Quality Control Market, accounting for 46.12% of the total market share. Diagnostics laboratories were depending on controls to ensure accurate test results regardless of the person doing the testing or the instrument being used. As a result, there was being robust demand for liquid controls, serum controls, and molecular diagnostic control products in the In Vitro Diagnostics Quality Control market. The clinical laboratory was performing thousands of routine diagnostic tests daily, and quality control products were providing consistent performance among analysers. Diagnostic laboratories were also beginning to implement multi-level control testing protocols utilizing two or three control products during each test cycle. Additional volume of diagnostics testing and growth of laboratory accreditation programs were helping support additional demand for standardized quality control products in the hospital and reference laboratory markets.

By Technology,

Based on the technology, the market was segmented into Immunochemistry, Clinical Chemistry, Hematology, Molecular Diagnostics, Coagulation / Haemostasis, Microbiology & Infectious Disease, and Point-Of-Care Testing. In 2025, the Clinical Chemistry segment dominated the In Vitro Diagnostics Quality Control Market, accounting for 33.41 % of the total market share. In areas where many clinical chemistry analyzers were being used for testing, the in vitro diagnostics quality control market was seeing many samples being run each week. For instance, large medical institutions were having dozens to hundreds of clinical chemistry labs that were processing over 1,200 clinical chemistry samples per day. Quality monitoring solutions were ensuring accurate calibration of biochemical analyzers, and laboratories were having internal control samples running continuously to validate analyzers and the reproducibility of testing. Due to the high number of clinical chemistry tests that were being performed in diagnostic chains, hospitals, and research labs, the in vitro diagnostics quality control market was also benefiting.

In Vitro Diagnostics Quality Control Market Region Analysis

In 2025, North America region dominated the In Vitro Diagnostics Quality Control Market with a share of 38.11 % of the global market. Throughout the U.S. and Canada, healthcare labs were establishing state-of-the-art lab infrastructure as well as stringent diagnostic quality standards. In particular, the In Vitro Diagnostics Quality Control market was seeing ongoing success in the implementation of laboratory accreditation programs, including those required for CAP and CLIA. Hospitals and chains of diagnostic facilities were all using "high-throughput" labs to generate many millions of diagnostic tests each year. Many healthcare facilities were also investing in automated lab systems and integrated quality monitoring platforms. In addition, diagnostic technology manufacturers were partnering with large hospital networks in order to improve diagnostic consistency. In summary, North America was being further solidified as a leader in the In Vitro Diagnostics Quality Control Market through robust growth in the volume of diagnostic tests, increased spending on healthcare, and widespread automation of laboratory testing.

In Vitro Diagnostics Quality Control Market Competitive Analysis

The in vitro diagnostics quality control market was featuring many worldwide diagnostic businesses that were devoting themselves to developing new products, partnering with laboratories, and offering digital quality management platforms. Leading manufacturers were developing multiple technological solutions for quality control of products that could be used with automated analyzers. Additionally, many firms were also developing cloud-based data management systems, which were allowing monitoring of the accuracy of diagnostics across numerous laboratory locations through the data being collected by the cloud. To further foster the adoption of their products, many strategic partnerships were being formed between diagnostic companies and laboratories. There was continuing to be a high level of activity in the in vitro diagnostics quality control market from product launches that were being related to immunochemistry, Hematology, and molecular diagnostic technologies. The primary players in the in vitro diagnostics quality control market were establishing their competitive positions through the automation of quality monitoring, improved analytics for laboratories, and the integration of laboratory information systems.

In Vitro Diagnostics Quality Control Market Report Scope:

Key Players –

Frequently Ask Questions –

1)    What is the In Vitro Diagnostics Quality Control Market?

Ans - The In Vitro Diagnostics Quality Control Market was referring to solutions used to maintain accuracy and reliability of laboratory diagnostic tests performed outside the human body.

2)    Why is the In Vitro Diagnostics Quality Control Market important?

Ans - The In Vitro Diagnostics Quality Control Market was supporting laboratory accuracy, helping laboratories maintain reliable diagnostic results and patient safety standards.

3)    Which laboratories were using solutions from the In Vitro Diagnostics Quality Control Market?

Ans - Hospital laboratories, reference laboratories, and diagnostic testing centers were actively using solutions from the In Vitro Diagnostics Quality Control Market.

4)    What technologies were influencing the In Vitro Diagnostics Quality Control Market?

Ans - Clinical chemistry, immunochemistry, molecular diagnostics, and Hematology technologies were strongly influencing the In Vitro Diagnostics Quality Control Market.

What trends were shaping the In Vitro Diagnostics Quality Control Market?

Ans - Automation, digital laboratory platforms, and cloud-based data monitoring systems were shaping the In Vitro Diagnostics Quality Control Market.

Report Payment

Single User:
$4199
Spreadsheet:
$2900
Corporate User:
$5500
bottom of page